Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline (Q43195244)
Jump to navigation
Jump to search
scientific article published on 13 January 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline |
scientific article published on 13 January 2010 |
Statements
1 reference
Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline (English)
1 reference
M Lafeber
1 reference
A M E Stades
1 reference
G D Valk
1 reference
M J Cramer
1 reference
F Teding van Berkhout
1 reference
P M J Zelissen
1 reference
13 January 2010
1 reference
1 reference
162
1 reference
4
1 reference
667-675
1 reference
Identifiers
1 reference
1 reference